Page 1071 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 1071

CHAPTER 59  Special Aspects of Perinatal & Pediatric Pharmacology         1057


                    TABLE 59–6   Determination of drug dosage from       Hansten PD, Horn JR:  Drug Interactions, Analysis and Management. Facts &
                                  surface area. 1                            Comparisons. [Quarterly.]
                                                                         International Liaison Committee on Resuscitation:  The International Liaison
                                                                             Committee on Resuscitation (ILCOR) consensus on science with treatment
                        Weight                                               recommendations for pediatric and neonatal patients: pediatric basic and
                                    Approximate   Surface    Percent of      advanced life support. Pediatrics 2006;117:e955.
                                                      2
                     (kg)    (lb)   Age          Area (m )  Adult Dose
                                                                         Iqbal MM, Sohhan T, Mahmud SZ: The effects of lithium, valproic acid, and
                     3       6.6     Newborn      0.2         12             carbamazepine during pregnancy and lactation. J  Toxicol Clin  Toxicol
                                                                             2001;39:381.
                     6       13.2    3 months     0.3         18         Ito S: Drug therapy for breast feeding women. N Engl J Med 2000;343:118.
                     10      22      1 year       0.45        28         Kearns GL et al: Developmental pharmacology—drug disposition, action and
                     20      44      5.5 years    0.8         48             therapy in infants and children. N Engl J Med 2003;349:1157.
                                                                         Koren G: Medication Safety during Pregnancy and Breastfeeding; A Clinician’s Guide,
                     30      66      9 years      1           60             4th ed. McGraw-Hill, 2006.
                     40      88      12 years     1.3         78         Koren G, Nordeng H: Antidepressant use during pregnancy: The benefit-risk ratio.
                                                                             Am J Obstet Gynecol 2012;207:157.
                     50      110     14 years     1.5         90
                                                                         Koren G, Pastuszak A: Prevention  of unnecessary pregnancy terminations by
                     60      132     Adult        1.7         102            counseling women on drug, chemical, and radiation exposure during the
                                                                             first trimester. Teratology 1990;41:657.
                     70      154     Adult        1.76        103
                                                                         Koren G, Pastuszak A, Ito E: Drugs in pregnancy. N Engl J Med 1998;
                    1 For example, if adult dose is 1 mg/kg, dose for 3-month-old infant would be 0.18 mg/kg   338:1128.
                    or 1.1 mg total.                                     Koren G et al: Sex differences in the pharmacokinetics and bioequivalence of the
                    Reproduced, with permission, from Silver HK, Kempe CH, Bruyn HB:  Handbook of   delayed-release combination of doxylamine succinate-pyridoxine hydro-
                    Pediatrics, 14th ed. Originally published by Lange Medical Publications. © 1983 by the   chloride: Implications for pharmacotherapy in pregnancy. J Clin Pharmacol
                    McGraw-Hill Companies, Inc.                              2013;53:1268.
                                                                         Madadi P et al: Pharmacogenetics of neonatal opioid toxicity following maternal
                                                                             use of codeine during breastfeeding: A case control study. Clin Pharmacol
                       Despite these approximations, only by conducting studies in   Ther 2009;85:31.
                    children can safe and effective doses for a given age group and   Namouz-Haddad S, Koren G: Fetal pharmacotherapy 2: Fetal arrhythmia.
                    condition be determined.                                 J Obstet Gynaecol Can 2013;35:1023.
                                                                         Pauwels S, Allegaert K: Therapeutic drug monitoring in neonates. Arch Dis Child
                                                                             2016;101:377.
                    REFERENCES                                           Peled N et al: Gastric-outlet obstruction induced by prostaglandin therapy in
                    Briggs GG, Freeman RK, Yaffe SJ:  Drugs in Pregnancy and Lactation: A Refer-  neonates. N Engl J Med 1992;327:505.
                        ence Guide to Fetal and Neonatal Risk, 10th ed. Wolters Kluwer/Lippincott   SickKids Drug Handbook and Formulary 2015/2016.  The Hospital for Sick
                        Williams & Wilkins, 2015.                            Children, Toronto.
                    de Wildt SN et al: Ontogeny of midazolam glucuronidation in preterm infants.   Tetelbaum M et al: Back to basics: Understanding drugs in children: Pharmacoki-
                        Eur J Clin Pharmacol 2010;66:165.                    netic maturation. Pediatr Rev 2005;26:321.
                    Gavin PJ, Yogev R: The role of protease inhibitor therapy in children with HIV   Van Lingen RA et al: The effects of analgesia in the vulnerable infant during the
                        infection. Paediatr Drugs 2002;4:581.                perinatal period. Clin Perinatol 2002;29:511.
   1066   1067   1068   1069   1070   1071   1072   1073   1074   1075   1076